- Home
- AMD vs NVO Comparison
AMD vs NVO Comparison
Compare AMD & NVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AMD
- NVO
- Stock Information
- Founded
- AMD 1969
- NVO 1923
- Country
- AMD United States
- NVO Denmark
- Employees
- AMD N/A
- NVO N/A
- Industry
- AMD Semiconductors
- NVO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- AMD Technology
- NVO Health Care
- Exchange
- AMD Nasdaq
- NVO Nasdaq
- Market Cap
- AMD 285.9B
- NVO 278.0B
- IPO Year
- AMD 1972
- NVO N/A
- Fundamental
- Price
- AMD $155.82
- NVO $54.29
- Analyst Decision
- AMD Buy
- NVO Buy
- Analyst Count
- AMD 36
- NVO 7
- Target Price
- AMD $174.18
- NVO $98.00
- AVG Volume (30 Days)
- AMD 48.8M
- NVO 14.9M
- Earning Date
- AMD 10-28-2025
- NVO 11-05-2025
- Dividend Yield
- AMD N/A
- NVO 2.27%
- EPS Growth
- AMD 107.70
- NVO 24.25
- EPS
- AMD 1.73
- NVO 3.93
- Revenue
- AMD $29,600,000,000.00
- NVO $49,108,936,497.00
- Revenue This Year
- AMD $29.34
- NVO $10.01
- Revenue Next Year
- AMD $21.23
- NVO $9.93
- P/E Ratio
- AMD $89.88
- NVO $13.81
- Revenue Growth
- AMD 27.17
- NVO 20.91
- 52 Week Low
- AMD $76.48
- NVO $45.05
- 52 Week High
- AMD $186.65
- NVO $138.22
- Technical
- Relative Strength Index (RSI)
- AMD 41.97
- NVO 43.87
- Support Level
- AMD $149.22
- NVO $54.60
- Resistance Level
- AMD $164.75
- NVO $57.35
- Average True Range (ATR)
- AMD 5.01
- NVO 1.15
- MACD
- AMD -2.35
- NVO 0.34
- Stochastic Oscillator
- AMD 30.32
- NVO 27.94
About AMD Advanced Micro Devices Inc.
Advanced Micro Devices designs a variety of digital semiconductors for markets such as PCs, gaming consoles, data centers, industrial, and automotive applications. AMD's traditional strength was in central processing units and graphics processing units used in PCs and data centers. Additionally, the firm supplies the chips found in prominent game consoles such as the Sony PlayStation and Microsoft Xbox. In 2022, the firm acquired field-programmable gate array leader Xilinx to diversify its business and augment its opportunities in key end markets such as data center and automotive.
About NVO Novo Nordisk A/S
With roughly one third of the global branded diabetes treatment market, Novo Nordisk is the leading provider of diabetes-care products in the world. Based in Denmark, the company manufactures and markets a variety of human and modern insulins, injectable diabetes treatments such as GLP-1 therapy, oral antidiabetic agents, and obesity treatments. Novo also has a biopharmaceutical segment (constituting less than 10% of revenue) that specializes in protein therapies for hemophilia and other disorders.